(Press-News.org) CHICAGO — Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard — and that could translate to vastly improved patient outcomes. A second study highlights how certain generative AI tools can empower adolescents by helping them to gather useful medical information.
Together, these findings spotlight the potential of AI to make a profound, positive difference in people’s lives when thoughtfully integrated into clinical laboratory medicine.
Lyme test offers hope for early, effective treatment
Each year, more than 475,000 Americans are diagnosed with Lyme disease — a number that is only expected to climb due to climate change expanding the range of areas where ticks can live. When caught early, the condition responds well to antibiotics. However, the typical test — called two-tier serology — detects early Lyme accurately only 30% of the time. It’s a significant missed opportunity, since more than half of Lyme patients not diagnosed or treated within the first few weeks of infection will develop long-term health problems such as fatigue, neurocognitive issues, and arthritis.
The new test leverages AI to offer major improvement. Its sensitivity and specificity are both over 90%, “meaning 9 out of 10 patients are going to get a correct diagnosis and receive appropriate treatment, which lowers the risk of chronic illness significantly,” said Holly Ahern, a microbiologist and chief scientific officer at ACES Diagnostics.
Ahern and team built on research in rhesus macaque monkeys, whose immune response to the bacteria causing Lyme is similar to humans, to develop a panel that looks for 10 proteins (antigens) and is completed as a single test. This approach is an improvement over the two-tier method, which may require up to four tests.
Next, they analyzed blood samples from humans, including 123 people with Lyme disease and 197 uninfected individuals, to test whether adding machine learning to the test could bolster performance by detecting unique immune patterns. “You and I might get infected by the same bacteria, but we might both produce different antibody responses to it,” said Ahern. “With these antigens matched with a decision-tree–based classifier, we can actually pick that up in each individual case.”
The team found an algorithm that improved accuracy across all disease stages, correctly flagging infection in over 90% of early cases (versus 27% with the standard method). They hope the test — which, according to Ahern, is relatively inexpensive and works on standard laboratory equipment — will be commercially available by the end of 2026.
Medicine-GPT as an informational tool for adolescents
A second study assessed Medicine-GPT, a doctor-developed, free-to-use ChatGPT custom model. The research focused on adolescents because they tend to be early tech adopters who frequently search for information online, often on topics they don’t feel comfortable discussing with adults.
“Medicine-GPT shows promise as a powerful tool for addressing adolescent health inquiries, outperforming ChatGPT-4 in completeness, reasoning, and overall medical helpfulness,” said Austin Jin, a high school research intern at Weill Cornell Medicine in New York.
Jin and team gathered over 100 clinical questions related to lab medicine and diagnostics from Reddit’s “Ask Doctors” forum, filtering for posts by people aged 10-19 and sorted by “top” interactions. They evaluated how well the customized chatbot provided useful answers compared to its predecessor, ChatGPT-4.
Both models demonstrated complete factual accuracy, but Medicine-GPT outperformed ChatGPT-4 on other measures, achieving ratings of 66.6% for completeness, 60% for reasoning, and 46.6% for helpfulness (compared to 20%, 33.3%, and 23.3%, respectively, for ChatGPT-4). Both models received high ratings on clarity (80% for Medicine-GPT vs. 70% for ChatGPT-4).
However, a common challenge is that these tools can leave teenagers feeling overwhelmed, especially when chatbots present rare, fatal conditions as diagnostic possibilities. “This highlights the need for future AI tools to not only be medically accurate, but also context-aware, user-sensitive, and aligned with how clinicians communicate,” Jin said.“Rather than discouraging use, providers can guide adolescents on how to use these tools responsibly, emphasizing that AI … should never replace professional medical advice or personalized evaluation.”
About ADLM 2025
ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo) offers 5 days packed with opportunities to learn about exciting science from July 27-31 in Chicago. Plenary sessions will explore urgent problems related to clinical artificial intelligence (AI) integration, fake medical news, and the pervasiveness of plastics, as well as tapping into the promise of genomics and microbiome medicine for personalized healthcare.
At the ADLM 2025 Clinical Lab Expo, more than 800 exhibitors will fill the show floor of the McCormick Place Convention Center in Chicago, with displays of the latest diagnostic technology, including but not limited to AI, point-of-care, and automation.
About the Association for Diagnostics & Laboratory Medicine (ADLM)
Dedicated to achieving better health for all through laboratory medicine, ADLM (formerly AACC) unites more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from 110 countries around the world. Our community is at the forefront of laboratory medicine’s diverse subdisciplines, including clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science, and is comprised of individuals holding the spectrum of lab-related professional degrees, certifications, and credentials. Since 1948, ADLM has championed the advancement of laboratory medicine by fostering scientific collaboration, knowledge sharing, and the development of innovative solutions that enhance health outcomes. For more information, visit www.myadlm.org.
END
Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatment
Together, these findings spotlight the potential of AI to make a profound, positive difference in people’s lives when thoughtfully integrated into clinical laboratory medicine
2025-07-28
ELSE PRESS RELEASES FROM THIS DATE:
CD4+ T cell-mediated immune drift in biologic treatment of inflammatory skin diseases
2025-07-28
Immune-inflammatory skin diseases (e.g., psoriasis, atopic dermatitis) involve dysregulation of CD4+ T-cell subsets (Th1/Th2/Th17/Treg) and cytokine networks (IL-17/IL-23/IL-4). Biologics targeting specific pathways—TNF-α, IL-17, IL-12/23, IL-4/13, PD-1/PD-L1—revolutionize treatment but trigger immune drift, shifting CD4+ T-cell polarization and causing adverse skin reactions. This review synthesizes mechanisms, clinical manifestations, and management strategies.
Mechanisms of Immune Drift by Biologic Class
(Summarized in Table 1)
1. TNF-α Inhibitors (Etanercept, Infliximab, Adalimumab)
Mechanism: Blocking ...
Spotlight on technology to protect older Australians from respiratory infections
2025-07-28
Simple technology that harnesses ultraviolet light to ‘zap’ airborne viruses has been shown to significantly lower the number of respiratory infections in aged care facilities, paving the way for smarter infection control.
Adapted by scientists from Flinders Health and Medical Research Institute (FHMRI) and SAHMRI, the technology is based on using germicidal ultraviolet (GUV) appliances which purify the air with UV-C light rays and deactivate harmful micro-organisms like viruses and bacteria.
The new study published in JAMA Internal Medicine trialled commercially-available GUV appliances in aged care facilities ...
There’s something in the air
2025-07-28
Researchers at the University of Tokyo explored how female body odor can influence behaviors in men. They found certain scent compounds in female body odor increased during ovulation and can subtly influence how men feel. When these scents were added to armpit odor samples, men rated them as more pleasant and faces associated with the samples as more attractive. The scents also seemed to reduce stress. The team states this is not evidence of pheromones in humans, but that smell might subtly shape how we people interact.
While they’re a common staple of pop culture, especially in romantic comedies, pheromones, behavior-altering ...
New insights could help phages defeat antibiotic resistant bacteria
2025-07-28
UNDER EMBARGO UNTIL 16:00 UK TIME (11:00 AM ET) ON MONDAY 28 JULY 2025
New insights could help phages defeat antibiotic resistant bacteria
Researchers at the University of Southampton have worked out how bacteria defend themselves against viruses called phages and the new insights could be key to tackling antibiotic resistance.
Phages are seen as a promising alternative treatment to antibiotics. Unpicking how bacteria protect themselves, and how phages might overcome these defences, could be a significant step in defeating antibiotic resistant bacteria.
Phages, ...
New system dramatically speeds the search for polymer materials
2025-07-28
Cambridge, MA – Scientists often seek new materials derived from polymers. Rather than starting a polymer search from scratch, they save time and money by blending existing polymers to achieve desired properties.
But identifying the best blend is a thorny problem. Not only is there a practically limitless number of potential combinations, but polymers interact in complex ways, so the properties of a new blend are challenging to predict.
To accelerate the discovery of new materials, MIT researchers ...
Safety of JN.1-updated mRNA COVID-19 vaccines
2025-07-28
About The Study: In this nationwide cohort study, no increased risk of 29 adverse events was observed after vaccination with the updated COVID-19 mRNA vaccine containing the SARS-CoV-2 Omicron JN.1 lineage in approximately 1 million adults.
Corresponding Author: To contact the corresponding author, Niklas Worm Andersson, MD, PhD, email nian@ssi.dk.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.23557)
Editor’s Note: Please see the article for additional information, ...
Type 2 diabetes and financial outcomes
2025-07-28
About The Study: The findings of this study suggest that patients with type 2 diabetes may experience substantially more adverse financial outcomes compared with patients without diabetes, highlighting the need to consider patient financial health when treating type 2 diabetes, particularly for patient groups at higher risk.
Corresponding Author: To contact the corresponding author, Cazilia Loibl, PhD, CFP, email loibl.3@osu.edu.
To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/
(doi:10.1001/jamanetworkopen.2025.23453)
Editor’s ...
A financial toll on patients with type 2 diabetes
2025-07-28
Embargoed until 11 a.m. ET, July 28, 2025
In a first-of-its-kind study, researchers used a unique dataset to show that patients with type 2 diabetes have significantly worse financial outcomes than other patients.
Findings showed diabetes patients fared worse on all seven financial outcomes studied, including below-prime credit scores, medical and non-medical debt in collections, 60-plus-day delinquent debt, debt charge-offs, bankruptcy filings and foreclosure.
The diabetes patients in this study were compared to people who had a blood test ...
Safflower yellow pigments in coronary heart disease: Mechanisms, applications, and future perspectives
2025-07-28
Coronary heart disease (CHD), characterized by atherosclerosis-induced myocardial ischemia, remains a leading cause of mortality in China. Safflower yellow pigments (SYPs), the primary bioactive components of Carthamus tinctorius L., consist mainly of quinochalcone C-glycosides, with hydroxysafflor yellow A (HSYA) and anhydrosafflor yellow B (AHSYB) as key constituents. This review synthesizes evidence on SYPs' mechanisms, therapeutic applications, and future directions in CHD management.
Chemical Composition and Pharmacokinetics
SYPs comprise over 20 identified compounds, including HSYA and AHSYB, which confer cardiovascular protection, anti-inflammatory, and antioxidant activities. ...
TraMA: new RNA-based measure predicts mortality risk and tracks aging
2025-07-28
“TraMA is likely to be of particular value to researchers interested in understanding the biological processes underlying health and aging, and for social, psychological, epidemiological, and demographic studies of health and aging.”
BUFFALO, NY — July 28, 2025 — A new research paper was published in Aging (Aging-US) Volume 17, Issue 6, on June 13, 2025, titled “Development of a novel transcriptomic measure of aging: Transcriptomic Mortality-risk Age (TraMA).”
In ...
LAST 30 PRESS RELEASES:
Moffitt studies uncover complementary strategies to overcome resistance to KRAS G12Cinhibitors in lung cancer
National summit of experts charts unprecedented roadmap to reduce harms from firearms in new ways
Global environmental DNA (eDNA) surveys significantly expand known geographic and ecological niche ranges of marine fish, highlighting current biases in conservation and ecological modeling
Hundreds of animal studies on brain damage after stroke flagged for problematic images
Prize winner’s research reveals how complex neural circuits are correctly wired during brain development
Supershear rupture sustained in thick fault zone during 2025 Mandalay earthquake, study in research package shows
Study reveals how brain cell networks stabilize memory formation
CTE: More than just head trauma, suggests new study
New psychology study suggests chimpanzees might be rational thinkers
Study links genetic variants to higher 'bad' cholesterol and heart attack risk
Myanmar fault had ideal geometry to produce 2025 supershear earthquake
Breakthrough in BRCA2 research: a novel mechanism behind chemoresistance discovered
New funding for health economics research on substance use disorder treatments
Tying protein to fraying DNA solves mystery of illness for patients around the world
MD Anderson shares latest research breakthroughs
19 women’s college basketball coaches join forces to improve women’s cardiovascular health
Palaeontology: How ammolite gemstones get their vivid colours
New study explores ‘legacy effects’ of soil microbes on plants across Kansas
Nanotyrannus confirmed: Dueling dinosaurs fossil rewrites the story of T. rex
How do planets get wet? Experiments show water creation during planet formation process
The diagnosis and evolving treatment landscape of systemic light chain amyloidosis
Lactylation in gynecological malignancies: a bridge between lactate metabolism and epigenetic therapy
Immune cell phenotypes, inflammatory proteins and epilepsy
Olfaction and coronary heart disease
Consistent adherence to physical activity guidelines and digestive system cancer risk and mortality
Beliefs about the effect of alcohol use on cancer risk in the us adult population
Comprehensive molecular profiling of renal medullary carcinoma identifies TROP2 as a promising therapeutic target
Breast cancer risk varies between different hormonal contraceptives
Immature brain-supporting cells switch fate to restore blood flow after stroke
Making more supply to meet the demands of muscle cell therapy
[Press-News.org] Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatmentTogether, these findings spotlight the potential of AI to make a profound, positive difference in people’s lives when thoughtfully integrated into clinical laboratory medicine